Breaking News Instant updates and real-time market news.

OXFD

Oxford Immunotec

$12.71

-0.17 (-1.32%)

16:08
10/12/16
10/12
16:08
10/12/16
16:08

Oxford Immunotec closes Immunetics acquisition, reiterates FY16 guidance

Oxford Immunotec Global announced it has closed a transaction to acquire Immunetics, a Massachusetts-based diagnostics company focused on developing specialized tests for infectious diseases, such as Lyme disease. Total consideration is comprised of $6M in cash and up to an additional $6M in cash payable on the achievement of certain revenue thresholds and pipeline related milestones over the next three years. Oxford expects the acquisition of Immunetics to contribute approximately $0.5M in revenues in Q4. Oxford continues to expect to report FY16 revenue of between $82.5M-$84.5M, consensus $83.51M. Oxford expects to have over $50M of cash at the end of 2016, excluding any draw-downs on its debt revolver.

  • 29

    Nov

OXFD Oxford Immunotec
$12.71

-0.17 (-1.32%)

06/20/16
PIPR
06/20/16
NO CHANGE
PIPR
Final PAMA rule better than expected, says Piper Jaffray
Piper Jaffray analyst William Quirk says the final Protecting Access to Medicare Act published Friday by Centers for Medicare & Medicaid Services is better than expected. PAMA is delayed until 2018 from 2017 as expected, Quirk tells investors in a research note. Hospital labs will be required to submit private payer rates to CMS, a positive relative to prior expectations, the analyst notes. He views the decision as beneficial for Quest Diagnostics (DGX) and LabCorp (LH). Further, CMS will require labs to submit only in-network rates and out-of-network "final" rates, which is a positive for specialty labs who have in-network rates at or above Medicare including CareDx (CDNA), Genomic Health (GHDX), Myriad Genetics (MYGN), Oxford Immunotec (OXFD) and Veracyte (VCYT), Quirk writes.
06/24/16
PIPR
06/24/16
NO CHANGE
Target $25
PIPR
Overweight
Piper Jaffray positive on Imugen acquisition by Oxford Immunotec
Piper Jaffray analyst William Quirk says the acquisition of Imugen, a clinical laboratory focused on developing and performing specialized testing for tick-borne diseases, by Oxford Immunotec is a "good strategic fit" given call point overlap. Oxford's vision is to leverage the exiting sales force and marketing infrastructure to grow its revenue in the U.S., the analyst tells investors in a research note. Quirck also notes that Oxford has more costs than revenue in GBP and today's GBP/USD movements following the "Brexit" vote could be a net benefit. He reiterates an Overweight rating and $25 price target on Oxford's shares.
07/07/16
PIPR
07/07/16
NO CHANGE
PIPR
New FDA recommendation positive for lab companies, says Piper Jaffray
Piper Jaffray analyst William Quirk says that the FDA has issued draft guidance to streamline its approval process for next-generation sequencing, or NGS, germline tests, which could be a substitute for a Premarket Notification or 510k. The analyst believes streamlined regulatory approaches for NGS tests are a positive for labs with NGS laboratory-developed tests such as CareDx (CDNA), Quest Diagnostics (DGX), Genomic Health (GHDX), LabCorp (LH), Myriad Genetics (MYGN), Natera (NTRA), Oxford Immunotec (OXFD), Sequenom (SQNM), Trovagene (TROV), and Veracyte (VCYT).

TODAY'S FREE FLY STORIES

BHP

BHP Billiton

$36.05

-0.29 (-0.80%)

07:05
04/27/17
04/27
07:05
04/27/17
07:05
Periodicals
Investors consider Elliott's demands for BHP amid shake-up, Reuters says »

Elliott Management's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MINI

Mobile Mini

$30.45

-0.15 (-0.49%)

07:04
04/27/17
04/27
07:04
04/27/17
07:04
Earnings
Mobile Mini reports Q1 adjusted EPS 25c, consensus 26c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 09

    May

F

Ford

$11.60

0.12 (1.05%)

07:04
04/27/17
04/27
07:04
04/27/17
07:04
Earnings
Ford backs FY17 adjusted pre-tax profit view of 'about' $9B »

For 2017, Ford continues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

CMCSA

Comcast

$38.79

0.3 (0.78%)

07:04
04/27/17
04/27
07:04
04/27/17
07:04
Earnings
Comcast reports Q1 adj. EPS 53c, consensus 44c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

ALKS

Alkermes

$57.13

0.13 (0.23%)

07:04
04/27/17
04/27
07:04
04/27/17
07:04
Earnings
Alkermes reiterates 2017 financial expectations »

The company said in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

  • 08

    Jun

MGNX

MacroGenics

$21.68

0.18 (0.84%)

07:04
04/27/17
04/27
07:04
04/27/17
07:04
Syndicate
MacroGenics announces $23.5M registered direcgt offering »

MacroGenics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 03

    May

  • 18

    May

AMZN

Amazon.com

$909.29

1.67 (0.18%)

07:03
04/27/17
04/27
07:03
04/27/17
07:03
Recommendations
Amazon.com analyst commentary  »

Amazon.com margins may…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 16

    May

  • 16

    May

  • 23

    May

F

Ford

$11.60

0.12 (1.05%)

07:03
04/27/17
04/27
07:03
04/27/17
07:03
Earnings
Ford reports Q1 adjusted EPS 39c, consensus 36c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

WDAY

Workday

$86.62

-0.25 (-0.29%)

07:03
04/27/17
04/27
07:03
04/27/17
07:03
Initiation
Workday initiated  »

Workday initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jun

  • 20

    Jun

PSTB

Park Sterling Bank

$12.52

0.23 (1.87%)

07:03
04/27/17
04/27
07:03
04/27/17
07:03
Earnings
Park Sterling Bank reports Q1 adjusted EPS 14c, consensus 13c »

Net interest margin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 15

    May

  • 25

    May

SIRI

Sirius XM

$5.11

-0.095 (-1.83%)

07:03
04/27/17
04/27
07:03
04/27/17
07:03
Earnings
Sirius XM sees FY17 revenue approximately $5.3B, consensus $5.35B »

Sees FY17: Self-pay net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 18

    May

AIT

Applied Industrial Technologies

$64.10

0.95 (1.50%)

07:03
04/27/17
04/27
07:03
04/27/17
07:03
Earnings
Applied Industrial Technologies raises FY17 EPS view to $2.74-$2.84 »

Previous FY17 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 09

    May

ALKS

Alkermes

$57.13

0.13 (0.23%)

07:03
04/27/17
04/27
07:03
04/27/17
07:03
Earnings
Alkermes reports Q1 EPS (18c), consensus (8c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

  • 04

    May

  • 06

    Jun

  • 08

    Jun

RTN

Raytheon

$155.27

-0.74 (-0.47%)

07:02
04/27/17
04/27
07:02
04/27/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Raytheon »

Raytheon reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

RTN

Raytheon

$155.27

-0.74 (-0.47%)

07:02
04/27/17
04/27
07:02
04/27/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Raytheon »

Raytheon reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

SIRI

Sirius XM

$5.11

-0.095 (-1.83%)

07:02
04/27/17
04/27
07:02
04/27/17
07:02
Hot Stocks
Sirius XM reports 31.6M subscribers in Q1 »

The company added 259,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 18

    May

PSTB

Park Sterling Bank

$12.52

0.23 (1.87%)

, SSB

South State

$91.90

1.35 (1.49%)

07:02
04/27/17
04/27
07:02
04/27/17
07:02
Hot Stocks
Park Sterling Bank, South State announce merger agreement »

South State Corporation…

PSTB

Park Sterling Bank

$12.52

0.23 (1.87%)

SSB

South State

$91.90

1.35 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 15

    May

  • 25

    May

AIT

Applied Industrial Technologies

$64.10

0.95 (1.50%)

07:02
04/27/17
04/27
07:02
04/27/17
07:02
Earnings
Applied Industrial Technologies sees Q4 EPS 68c-78c, consensus 68c »

Sees Q4 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 09

    May

RTN

Raytheon

$155.27

-0.74 (-0.47%)

07:02
04/27/17
04/27
07:02
04/27/17
07:02
Earnings
Raytheon reports Q1 EPS $1.73, consensus $1.61 »

Reports Q1 revenue $6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

SIRI

Sirius XM

$5.11

-0.095 (-1.83%)

07:01
04/27/17
04/27
07:01
04/27/17
07:01
Earnings
Sirius XM reports Q1 EPS 4c, consensus 4c »

Reports Q1 revenue $1.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 18

    May

AIT

Applied Industrial Technologies

$64.10

0.95 (1.50%)

07:01
04/27/17
04/27
07:01
04/27/17
07:01
Earnings
Applied Industrial Technologies reports Q3 EPS 75c, consensus 63c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 09

    May

BMY

Bristol-Myers

$53.77

-0.17 (-0.32%)

07:00
04/27/17
04/27
07:00
04/27/17
07:00
Earnings
Bristol-Myers reports Q1 adjusted EPS 84c, consensus 74c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 03

    May

  • 06

    Jun

ANTM

Anthem

$179.03

6.57 (3.81%)

07:00
04/27/17
04/27
07:00
04/27/17
07:00
Upgrade
Anthem rating change  »

Anthem upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

SHOP

Shopify

$74.12

-2.53 (-3.30%)

07:00
04/27/17
04/27
07:00
04/27/17
07:00
Downgrade
Shopify rating change  »

Shopify downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 24

    May

I

Intelsat

$3.73

-0.08 (-2.10%)

06:59
04/27/17
04/27
06:59
04/27/17
06:59
Earnings
Intelsat backs FY17 revenue view $2.18B-$2.23B, consensus $2.19B »

Backs FY17 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.